Found: 20
Select item for more details and to access through your institution.
Anxiogenic Effect of Cholecystokinin in the Dorsal Periaqueductal Gray.
- Published in:
- Neuropsychopharmacology, 2004, v. 29, n. 1, p. 101, doi. 10.1038/sj.npp.1300334
- By:
- Publication type:
- Article
Cannabidiol Confers Neuroprotection in Rats in a Model of Transient Global Cerebral Ischemia: Impact of Hippocampal Synaptic Neuroplasticity.
- Published in:
- Molecular Neurobiology, 2021, v. 58, n. 10, p. 5338, doi. 10.1007/s12035-021-02479-7
- By:
- Publication type:
- Article
Increased blood neutrophil extracellular traps (NETs) associated with early life stress: translational findings in recent-onset schizophrenia and rodent model.
- Published in:
- Translational Psychiatry, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41398-022-02291-4
- By:
- Publication type:
- Article
Inhibition of neuronal nitric oxide synthase in the rat hippocampus induces antidepressant-like effects.
- Published in:
- Psychopharmacology, 2006, v. 185, n. 3, p. 298, doi. 10.1007/s00213-006-0326-2
- By:
- Publication type:
- Article
Anxiolytic-like effects induced by nitric oxide synthase inhibitors microinjected into the medial amygdala of rats.
- Published in:
- Psychopharmacology, 2006, v. 184, n. 2, p. 166, doi. 10.1007/s00213-005-0270-6
- By:
- Publication type:
- Article
Ionotropic glutamate-receptor antagonists inhibit the aversive effects of nitric oxide donor injected into the dorsolateral periaqueductal gray of rats.
- Published in:
- Psychopharmacology, 2004, v. 171, n. 2, p. 199, doi. 10.1007/s00213-003-1569-9
- By:
- Publication type:
- Article
The Expression of Contextual Fear Conditioning Involves Activation of an NMDA Receptor–Nitric Oxide Pathway in the Medial Prefrontal Cortex.
- Published in:
- Cerebral Cortex, 2008, v. 18, n. 9, p. 2027, doi. 10.1093/cercor/bhm232
- By:
- Publication type:
- Article
Canabidiol e compostos canabinoides como potenciais estratégias para atenuação da discinesia induzida por l-dopa.
- Published in:
- Universidade Estadual Paulista. Revista de Odontologia, 2023, v. 52, p. 210
- By:
- Publication type:
- Article
The two synthetic cannabinoid compounds 4′‐F‐CBD and HU‐910 efficiently restrain inflammatory responses of brain microglia and astrocytes.
- Published in:
- Glia, 2024, v. 72, n. 3, p. 529, doi. 10.1002/glia.24489
- By:
- Publication type:
- Article
Anxiolytic-like effect of group housing on stress-induced behavior in rats.
- Published in:
- Depression & Anxiety (1091-4269), 2003, v. 18, n. 3, p. 149, doi. 10.1002/da.10124
- By:
- Publication type:
- Article
Differential contribution of CB1, CB2, 5‐HT1A, and PPAR‐γ receptors to cannabidiol effects on ischemia‐induced emotional and cognitive impairments.
- Published in:
- European Journal of Neuroscience, 2021, v. 53, n. 6, p. 1738, doi. 10.1111/ejn.15134
- By:
- Publication type:
- Article
The anxiolytic effect of cannabidiol depends on the nature of the trauma when patients with post-traumatic stress disorder recall their trigger event.
- Published in:
- Brazilian Journal of Psychiatry / Revista Brasileira de Psiquiatria, 2022, v. 44, n. 3, p. 298, doi. 10.1590/1516-4446-2021-2317
- By:
- Publication type:
- Article
Effects of cannabidiol, a Cannabis sativa constituent, on oral wound healing process in rats: Clinical and histological evaluation.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Electrodermically Nonresponsive Schizophrenia Patients Make More Errors in the Stroop Color Word Test, Indicating Selective Attention Deficit.
- Published in:
- Schizophrenia Bulletin, 2002, v. 28, n. 3, p. 459, doi. 10.1093/oxfordjournals.schbul.a006953
- By:
- Publication type:
- Article
Repeated treatment with nitric oxide synthase inhibitor attenuates learned helplessness development in rats and increases hippocampal BDNF expression.
- Published in:
- Acta Neuropsychiatrica, 2018, v. 30, n. 3, p. 127, doi. 10.1017/neu.2017.28
- By:
- Publication type:
- Article
Cannabidiol and Cannabinoid Compounds as Potential Strategies for Treating Parkinson's Disease and l-DOPA-Induced Dyskinesia.
- Published in:
- Neurotoxicity Research, 2020, v. 37, n. 1, p. 12, doi. 10.1007/s12640-019-00109-8
- By:
- Publication type:
- Article
Effects of Cannabidiol on Diabetes Outcomes and Chronic Cerebral Hypoperfusion Comorbidities in Middle-Aged Rats.
- Published in:
- Neurotoxicity Research, 2019, v. 35, n. 2, p. 463, doi. 10.1007/s12640-018-9972-5
- By:
- Publication type:
- Article
Effects of cannabidiol on symptoms induced by the recall of traumatic events in patients with posttraumatic stress disorder.
- Published in:
- Psychopharmacology, 2022, v. 239, n. 5, p. 1499, doi. 10.1007/s00213-021-06043-y
- By:
- Publication type:
- Article
Cannabidiol on 5‐FU‐induced oral mucositis in mice.
- Published in:
- Oral Diseases, 2020, v. 26, n. 7, p. 1483, doi. 10.1111/odi.13413
- By:
- Publication type:
- Article
Cannabidiol as an Adjunctive Treatment for Acute Bipolar Depression: A Pilot Study: Le cannabidiol comme traitement d'appoint de la dépression bipolaire aiguë : une étude pilote.
- Published in:
- Canadian Journal of Psychiatry, 2024, v. 69, n. 4, p. 242, doi. 10.1177/07067437231209650
- By:
- Publication type:
- Article